IL1R1 and serum lipopolysaccharide activity: Gene-targeted studies demonstrate that SIGIRR acts as a nonredundant negative regulator in dampening IL-1R and TLR-induced inflammation and tissue damage, including tuberculosis, candidiasis, aspergillosis, Pseudomonas aeruginosa infection and endotoxemia [18, 23, 33, 36, 37].